Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 32 (2019): Issue 3 (September 2019)
Open Access
Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
Roman Yarema
Roman Yarema
,
Nataliya Volodko
Nataliya Volodko
,
Taras Fetsych
Taras Fetsych
,
Myron Оhorchak
Myron Оhorchak
,
Orest Petronchak
Orest Petronchak
,
Yuriy Mylyan
Yuriy Mylyan
and
Halyna Makukh
Halyna Makukh
| Sep 28, 2019
Current Issues in Pharmacy and Medical Sciences
Volume 32 (2019): Issue 3 (September 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Sep 28, 2019
Page range:
154 - 159
Received:
Jan 08, 2019
Accepted:
Mar 27, 2019
DOI:
https://doi.org/10.2478/cipms-2019-0028
Keywords
ovarian cancer
,
peritoneal carcinomatosis
,
cytoreductive surgery
,
hyperthermic intraperitoneal chemotherapy
,
p53
,
BRCA 1
© 2019 Roman Yarema et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.